Thanks to the increasing understanding of the mechanisms of rheumatic diseases, research is underway worldwide on new drugs that can even more effectively support the treatment of these conditions. However, before a drug can be registered and approved for widespread use, it must undergo detailed studies to confirm its effectiveness and safety.
Clinical trials involve monitoring patients who, according to a specific medical protocol, receive modern therapies. During these trials, the drug’s effectiveness and safety are assessed, often in comparison to existing treatments or placebos.
Participation in a clinical trial is conducted under strict medical supervision and in accordance with applicable medical standards.
Another type of clinical trial compares the effectiveness and safety of a drug that has been on the market for some time with its equivalent, manufactured by another company seeking to introduce its product to the market.
Patients most often eligible for clinical trials are those whose current standard treatment isn’t delivering the expected results – for example, despite medication, active inflammation persists. Participating in a trial may then offer an opportunity to benefit from a new treatment method that will potentially improve disease control and quality of life.
During a clinical trial, patients are not responsible for any costs associated with doctor visits, laboratory tests, or the medication they take. The entire process is conducted under the strict supervision of a medical team and in accordance with applicable safety standards.